An open-label dose-escalating study evaluating the safety, pharmacokinetics and antiviral activity of IMC-M113V in HLA-A*02:01 positive, virologically suppressed subjects with chronic HIV infection

A Phase 3, Randomized, Observer-blind, Active-controlled Study to Investigate the Safety, Reactogenicity, and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine Compared with a Licensed Inactivated Seasonal Influenza Vaccine in Adults ≥50 Years of Age

A Phase 3, Randomized, Observer-blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of mRNA-1403, a Multivalent Candidate Vaccine to Prevent Norovirus Acute Gastroenteritis in Adults ≥18 Years of Age

Staphylococcus aureus Network Adaptive Platform trial

Phase 3 Multicenter, Randomized, Double-Blind, Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in HBeAg_negative Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B Virus

Define Appendix 3 (VST Therapy)

Measuring the impact of Improved Diagnostics on Antimicrobial Stewardship in Respiratory Tract Infection

Phase 1/2, randomized, observer-blind, dose-ranging study to evaluate the safety, reactogenicity, and immunogenicity of mRNA-1018 pandemic influenza candidate vaccines in healthy adults ≥18 years of age

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA)

A randomised, observer-blind, active-controlled Phase 3 study to investigate the safety, immunogenicity, and relative vaccine efficacy of mRNA-1283.222 administered as a booster dose compared with mRNA-1273.222 in participants aged 12 years and older for the prevention of COVID-19

Randomised Evaluation of COVID-19 Therapy

Platform Adaptive trial of NOvel antiviRals for eArly treatMent of covid-19 In the Community

A randomised placebo controlled trial of ART plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) vs ART plus placebo in treated Primary HIV Infection on viral control off ART